1 January 2009 in Journal of Biomedical Optics
We designed, fabricated and tested the laser optoacoustic imaging system for breast cancer detection (LOIS-64), which fuses optical and acoustic imaging techniques in one modality by utilizing pulsed optical illumination and ultrawide-band ultrasonic detection of resulting optoacoustic (OA) signals. The system was designed to image a single breast slice in craniocaudal or mediolateral projection with an arc-shaped array of 64 ultrawide-band acoustic transducers. The system resolution on breast phantoms was at least 0.5 mm. The single-channel sensitivity of 1.66 mV/Pa was estimated to be sufficient for single-pulse imaging of 6 to 11 mm tumors through the whole imaging slice of the breast. The implemented signal processing using the wavelet transform allowed significant reduction of the low-frequency (LF) acoustic noise, allowed localization of the optoacoustic signals from tumors, and enhanced the contrast and sharpened the boundaries of the optoacoustic images of the tumors. During the preliminary clinical studies on 27 patients, the LOIS-64 was able to visualize 18 out of 20 malignant lesions suspected from mammography and ultrasound images and confirmed by the biopsy performed after the optoacoustic tomography (OAT) procedure.
1 November 2009 in Journal of Biomedical Optics
We develop a system for three-dimensional whole-body optoacoustic tomography of small animals for applications in preclinical research. The tomographic images are obtained while the objects of study (phantoms or mice) are rotated within a sphere outlined by a concave arc-shaped array of 64 piezocomposite transducers. Two pulsed lasers operating in the near-IR spectral range (755 and 1064 nm) with an average pulsed energy of about 100 mJ, a repetition rate of 10 Hz, and a pulse duration of 15 to 75 ns are used as optical illumination sources. During the scan, the mouse is illuminated orthogonally to the array with two wide beams of light from a bifurcated fiber bundle. The system is capable of generating images of individual organs and blood vessels through the entire body of a mouse with spatial resolution of ~0.5 mm.
1 March 2010 in Journal of Biomedical Optics
We present our findings from a real-time laser optoacoustic imaging system (LOIS). The system utilizes a Q-switched Nd:YAG laser; a standard 128-channel ultrasonic linear array probe; custom electronics and custom software to collect, process, and display optoacoustic (OA) images at 10 Hz. We propose that this system be used during preoperative mapping of forearm vessels for hemodialysis treatment. To demonstrate the real-time imaging capabilities of the system, we show OA images of forearm vessels in a volunteer and compare our results to ultrasound images of the same region. Our OA images show blood vessels in high contrast. Manipulations with the probe enable us to locate and track arteries and veins of a forearm in real time. We also demonstrate the ability to combine a series of OA image slices into a volume for spatial representation of the vascular network. Finally, we use frame-by-frame analysis of the recorded OA video to measure dynamic changes of the crossection of the ulnar artery.
1 March 2010 in Journal of Biomedical Optics
Optoacoustic (OA) tomography has demonstrated utility in identifying blood-rich malignancies in breast tissue. We describe the development and characterization of a laser OA imaging system for the prostate (LOIS-P). The system consists of a fiber-coupled Q-switched laser operating at 757 nm, a commercial 128-channel ultrasonic probe, a digital signal processor, and software that uses the filtered radial back-projection algorithm for image reconstruction. The system is used to reconstruct OA images of a blood-rich lesion induced in vivo in a canine prostate. OA images obtained in vivo are compared to images acquired using ultrasound, the current gold standard for guiding biopsy of the prostate. Although key structural features such as the urethra could be identified with both imaging techniques, a bloody lesion representing a highly vascularized tumor could only be clearly identified in OA images. The advantages and limitations of both forward and backward illumination modes are also evaluated by collecting OA images of phantoms simulating blood vessels within tissue. System resolution is estimated to be 0.2 mm in the radial direction of the acoustic array. The minimum detectable pressure signal is 1.83 Pa. Our results encourage further development toward a dual-modality OA/ultrasonic system for prostate imaging and image-guided biopsy.
15 June 2012 in Journal of Biomedical Optics
A variety of optical contrast agents were proposed to enhance the quality and specificity of in vivo optical and optoacoustic (OA) imaging.1 2. 3. – 4 The reported biological effects observed upon administration of a contrast agent are mostly limited to its accumulation in the region of interest, e.g., a cancer tumor, either via targeted delivery or by passive transport.5 6. – 7 Recent trends in development of optical contrast agents are associated with different types of nanoparticles8. Despite large imaging potential, nanoparticles present inherent biological risks and challenges. Although in vitro and in vivo studies have demonstrated the absence of immediate toxicity for different types of nanoparticles, the legitimate concerns related to their potential long-term toxicity and relatively slow clearance rates remain poorly addressed.9 As the technologies that employ nanoparticle contrast agents approach commercial applications, there is more interest in studying long-term toxicity and biological distribution of nanoparticles.5
1 March 2023 in Journal of Biomedical Optics
Photoacoustic (PA) imaging (PAI) is an emerging imaging modality that takes advantage of the optical absorption properties of tissue to generate high-resolution in vivo images of anatomy and exogenous chromophores.1 PAI works through the PA effect: pulsed light delivered to a sample is absorbed, thereby causing thermoelastic expansion and generating acoustic pressure waves.2,3 These acoustic waves are detected by an ultrasound transducer and reconstructed to form an image. In the near-infrared (NIR) window, oxyhemoglobin and deoxyhemoglobin have relatively high optical absorption coefficients compared to other endogenous chromophores, enabling PAI to detect and highlight blood-rich tissues in vivo with a spatial resolution comparable to ultrasound imaging.4 – 8 The high contrast and sensitivity of these blood-rich tissues are responsible for PAI’s suitability as a functional and anatomical imaging modality. Additionally, PA contrast agents are designed with optical absorption properties that can be exploited with multispectral (i.e., multiwavelength) PAI.9 – 14